Dr Simon Brooks
Prosiectau fel Prif Ymchwiliwr
2 o 2
- Evaluation of mHtt knock-down therapy in R6/2 and HdhQ111 Huntington's disease line (01.04.2016 - 31.03.2017)
Prosiectau fel Cyd-Ymchwiliwr
- A comparative study of behavioural, anatomical and molecular changes in models of Huntington's disease (01.01.2010 - 31.12.2011)
- A comparative study of behavioural and molecular changes in models of Huntington's disease (01.01.2008 - 31.12.2009)
- Novel "Biased" GLP-1 agonist peptides for the treatment of neurodegenerative diseases: Assessment of CNS penetrance (01.07.2017 - 31.08.2018)
Thomson Reuters Deutschland GmbH
Zur Giesserei 2
D-76227 Karlsruhe | Germany